Companies that own Onxeo S.A.
Dimensional Fund Advisors LP
517,271
1.02%
18,764
0%
04/30/2018
Générali Investments Europe SpA SGR (France)
256,250
0.5%
126,875
0.01%
12/30/2016
La Banque Postale Asset Management SA
160,082
0.31%
0
0%
06/29/2018
Tocqueville Finance SA
92,959
0.18%
0
0.01%
06/29/2018
Danske Bank A/S (Investment Management)
48,269
0.1%
23,932
0%
08/31/2018
SSgA Funds Management, Inc.
47,990
0.09%
186
0%
09/06/2018
PlusAlpina Real Estate Advisors GmbH
45,713
0.09%
23,932
0.12%
08/31/2018
Dimensional Fund Advisors Ltd.
39,485
0.08%
8,340
0%
11/30/2017
Aviva Investors France SA
18,089
0.04%
0
0%
08/31/2018
Vega Investment Managers SA
12,000
0.02%
2,000
0%
06/30/2017
| Address |
49, blvd. du Général Martial Valin
Paris Ile-de-France 75015
France
|
|
Employees
|
- |
| Website |
http://www.onxeo.com |
| Updated |
07/08/2019 |
| Onxeo SA is a biotechnology company, which engages in the development of drugs for the treatment of orphan diseases. It produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Gilles Avenard and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France. |
